Glaxosmithkline Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2025 ,inter alia, to consider and approve Board Meeting Intimation
GLAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that a meeting of its Board of Directors is scheduled for 1st August 2025. The agenda includes considering and approving matters, among other things (inter alia). Specific agenda items have not been disclosed in this intimation. The company is required to inform the stock exchange of board meetings under listing regulations. Shareholders and analysts will typically look out for the outcome, which may include financial results, dividend decisions, or other significant corporate actions.
No immediate impact on shareholders — this is a routine regulatory intimation. Investors should await the post-meeting outcome for any material decisions on results, dividends, or strategic matters.